Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM — Stella

Home/Embolic Stroke of Undetermined Source/AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM

View on ClinicalTrials.gov

Recruiting

Back to Embolic Stroke of Undetermined Source trials

AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM

Trial locations(5 sites)

South Korea

Korea University Ansan Hospital, Ansan

Inha University Hospital, Incheon

Jeju National University Hospital, Jeju City

Korea University Guro Hospital, Seoul

Ajou University Hospital, Suwon

Key details

Sponsor

Inha University Hospital

Collaborators

DeepCardio Co., Ltd.

Enrollment target

~92 participants

Started

November 2025

Primary completion

May 2027

Age range

30 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.